what are the Recommendations for Renin-Angiotensin System Inhibition With ACEi
or ARB or ARNi
Referenced studies that support the recommendations are
summarized in the Online Data Supplements.?
In patients with chronic symptomatic HFrEF NYHA class II or III who tolerate an ACEi or ARB, replacement by an ARNi is recommended to further reduce morbidity and mortality.